Prolife Industries Ltd
PROLIFE NSE
Prolife Industries Ltd
ChemicalsNSE: PROLIFE Dyes & Pigments
Key Fundamentals
SMEDyes & PigmentsChemicalsMarket Cap
₹32.34 Cr
Volatility
Moderate
P/E Ratio
7.6
EBITDA
₹4.10 Cr
Return on Equity
10.29%
Debt to Equity
0.01
Book Value
₹121.16
52W High
₹142.45
52W Low
₹56.05
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Prolife Industries Ltd insights
29 extracted metrics + investor summaries across FY15–FY26.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Strengths
3- Company has reduced debt.
- Company is almost debt free.
- Stock is trading at 0.65 times its book value
Weaknesses
5- The company has delivered a poor sales growth of -5.80% over past five years.
- Company has a low return on equity of 13.9% over last 3 years.
- Earnings include an other income of Rs.2.84 Cr.
- Debtor days have increased from 54.0 to 71.8 days.
- Working capital days have increased from 69.6 days to 110 days
Growth Rate
Revenue Growth
-5.18% ↘
Net Income Growth
-9.57% ↘
Cash Flow Change
-98.10% ↘
ROE
-51.85% ↘
ROCE
-49.13% ↘
EBITDA Margin (Avg.)
-46.92% ↘
Quarterly Results
| Mar 2020 | Sep 2020 | Mar 2021 | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 27.18 | 33.33 | 40.26 | 34.89 | 38.31 | 42.96 | 35.36 | 29.86 | 26.96 | 26.68 | 28.79 | 28.75 | 25.77 |
| Expenses | 23.86 | 29.09 | 36.31 | 31.05 | 36.18 | 38.44 | 31.15 | 22.93 | 22.08 | 21.58 | 28.22 | 26.61 | 23.81 |
| Operating Profit | 3.32 | 4.24 | 3.95 | 3.84 | 2.13 | 4.52 | 4.21 | 6.93 | 4.88 | 5.1 | 0.57 | 2.14 | 1.96 |
| OPM % | 12.21% | 12.72% | 9.81% | 11.01% | 5.56% | 10.52% | 11.91% | 23.21% | 18.1% | 19.12% | 1.98% | 7.44% | 7.61% |
| Other Income | 1.1 | 0.23 | 0.39 | 0.51 | 1.11 | 0.85 | 1.33 | 0.51 | 1.08 | 0.45 | 1.63 | 0.55 | 2.29 |
| Interest | 0.1 | 0.29 | 0.2 | 0.25 | 0.21 | 0.39 | 0.03 | 0.2 | 0.13 | 0.18 | 0.15 | 0.09 | 0 |
| Depreciation | 0.52 | 0.5 | 0.43 | 0.48 | 0.68 | 0.62 | 0.63 | 0.62 | 0.59 | 0.56 | 0.54 | 0.59 | 0.4 |
| PBT | 3.8 | 3.68 | 3.71 | 3.62 | 2.35 | 4.36 | 4.88 | 6.62 | 5.24 | 4.81 | 1.51 | 2.01 | 3.85 |
| Tax % | 28.42% | 26.09% | 25.34% | 20.72% | 39.15% | 20.87% | 28.89% | 25.08% | 27.48% | 21.83% | 38.41% | 25.87% | 28.31% |
| Net Profit | 2.72 | 2.73 | 2.77 | 2.87 | 1.43 | 3.45 | 3.46 | 4.96 | 3.8 | 3.75 | 0.92 | 1.49 | 2.76 |
| EPS in Rs | 6.64 | 6.67 | 6.77 | 7.01 | 3.49 | 8.43 | 8.45 | 12.11 | 9.28 | 9.16 | 2.25 | 3.64 | 6.74 |
Profit & Loss
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 19.58 | 22.19 | 27.14 | 27.2 | 29.58 | 50.38 | 73.5 | 73.08 | 78.15 | 56.81 | 55.35 | 54.52 |
| Expenses | 17.76 | 20.39 | 24.6 | 23.65 | 25.38 | 44.82 | 65.28 | 67.1 | 69.41 | 45 | 49.67 | 50.42 |
| Operating Profit | 1.82 | 1.8 | 2.54 | 3.55 | 4.2 | 5.56 | 8.22 | 5.98 | 8.74 | 11.81 | 5.68 | 4.1 |
| OPM % | 9.3% | 8.11% | 9.36% | 13.05% | 14.2% | 11.04% | 11.18% | 8.18% | 11.18% | 20.79% | 10.26% | 7.52% |
| Other Income | 0.31 | 0.45 | 0.1 | 0.27 | 0.46 | 1.78 | 0.62 | 1.63 | 2.18 | 1.59 | 2.08 | 2.84 |
| Interest | 1.11 | 1.01 | 0.84 | 0.84 | 0.91 | 0.63 | 0.52 | 0.48 | 0.43 | 0.33 | 0.34 | 0.09 |
| Depreciation | 0.4 | 0.42 | 0.47 | 0.89 | 0.93 | 1.03 | 0.93 | 1.16 | 1.25 | 1.21 | 1.1 | 0.98 |
| PBT | 0.62 | 0.82 | 1.33 | 2.09 | 2.82 | 5.68 | 7.39 | 5.97 | 9.24 | 11.86 | 6.32 | 5.87 |
| Tax % | 37.1% | 35.37% | 33.83% | 28.23% | 28.01% | 28.87% | 25.58% | 27.97% | 25.11% | 26.14% | 25.79% | 27.43% |
| Net Profit | 0.4 | 0.53 | 0.87 | 1.5 | 2.04 | 4.04 | 5.5 | 4.3 | 6.91 | 8.76 | 4.68 | 4.25 |
| EPS in Rs | 2.68 | 3.55 | 2.13 | 3.66 | 4.98 | 9.87 | 13.43 | 10.5 | 16.88 | 21.4 | 11.43 | 10.38 |
| Div. Payout % | 8.94% | 7.03% | 9.4% | 6.82% | 6.01% | 3.04% | 2.23% | 2.85% | 1.78% | 2.33% | 2.62% | 2.89% |
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1.49 | 1.49 | 4.09 | 4.09 | 4.09 | 4.09 | 4.09 | 4.09 | 4.09 | 4.09 | 4.09 | 4.09 |
| Reserves | 1.53 | 2.1 | 4.59 | 6 | 8.03 | 11.92 | 17.3 | 21.48 | 28.27 | 36.9 | 41.38 | 45.51 |
| Borrowings | 10.1 | 8.61 | 5.07 | 4.82 | 7.15 | 7.71 | 5.49 | 4.71 | 1.92 | 3.81 | 2.58 | 0.27 |
| Other Liabilities | 4.57 | 3.84 | 4.77 | 6.22 | 7.42 | 11.94 | 21.75 | 25.15 | 6.88 | 7.12 | 5.27 | 4.52 |
| Total Liabilities | 17.69 | 16.04 | 18.52 | 21.13 | 26.69 | 35.66 | 48.63 | 55.43 | 41.16 | 51.92 | 53.32 | 54.39 |
| Fixed Assets | 2.73 | 3.21 | 8.11 | 9.56 | 10.04 | 9.6 | 9.34 | 11.43 | 11.36 | 11.29 | 10.51 | 7.87 |
| CWIP | 0.13 | 0.57 | 0.53 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 2.87 | 2.81 | 1.52 | 1.77 | 1.76 | 1.22 | 1.22 | 1.22 | 1.21 | 1.21 | 1.21 | 3.56 |
| Other Assets | 11.96 | 9.45 | 8.36 | 9.8 | 14.89 | 24.84 | 38.07 | 42.78 | 28.59 | 39.42 | 41.6 | 42.96 |
| Total Assets | 17.69 | 16.04 | 18.52 | 21.13 | 26.69 | 35.66 | 48.63 | 55.43 | 41.16 | 51.92 | 53.32 | 54.39 |
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 0.02 | 4.15 | -0.08 | 5.84 | 0.81 | 10.02 | 5.11 | 3.73 | 0.05 | 17.33 | 0.33 | -1.64 |
| Investing | -0.17 | -1.41 | -3.28 | -3.27 | -2.33 | -4.69 | -5.64 | -3.05 | 1.46 | 3.49 | -2.76 | 2.66 |
| Financing | 0.47 | -2.86 | 3.3 | -1.86 | 1.63 | -3.74 | -1.31 | -0.14 | -1.43 | -0.72 | -1.69 | -2.32 |
| Net Cash Flow | 0.33 | -0.13 | -0.06 | 0.71 | 0.1 | 1.58 | -1.84 | 0.54 | 0.08 | 20.11 | -4.12 | -1.31 |
| Free Cash Flow | -0.82 | 2.82 | -2.9 | 4.04 | -0.59 | 9.43 | 4.44 | 0.48 | -1.08 | 16.18 | 0.01 | -2.56 |
| CFO/OP | 15 | 249 | 17 | 180 | 38 | 210 | 85 | 91 | 27 | 173 | 35 | -1 |
Ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 62.64 | 63.66 | 57.56 | 38.11 | 100 | 52.16 | 78.46 | 83.76 | 49.55 | 34.44 | 55.79 | 71.77 |
| Inventory Days | 171 | 69.16 | 43.03 | 65.17 | 37.05 | 62.59 | 52.32 | 76.79 | 39.4 | 63.68 | 68.39 | 96.46 |
| Days Payable | 91.39 | 68.73 | 71.78 | 104 | 105 | 89.97 | 124 | 150 | 25.99 | 37.71 | 30.18 | 21.16 |
| Cash Conversion Cycle | 142 | 64.08 | 28.81 | -0.84 | 32.93 | 24.78 | 6.45 | 10.66 | 62.96 | 60.41 | 94 | 147 |
| Working Capital Days | 87.61 | 40.46 | 54.06 | 18.12 | 54.91 | 0.07 | 8.94 | 19.58 | 57.54 | 28.98 | 70.1 | 110 |
| ROCE % | 13.7% | 14.93% | 16.57% | 20.31% | 21.83% | 29.03% | 30.83% | 22.57% | 29.96% | 30.83% | 14.35% | 12.17% |
Documents
1
Outcome of Board Meeting
26 Aug - Board approved 3% final dividend, 32nd AGM on September 25, 2026, and book closure September 19-25, 2026. 26 Aug - Board approved 3% final dividend, 32nd AGM on September 25, 2026, and book closure September 19-25, 2026.
2
Record Date
26 Aug - Board approved 3% final dividend, AGM on September 25, 2026, and book closure dates. 26 Aug - Board approved 3% final dividend, AGM on September 25, 2026, and book closure dates.
3
Reply to Clarification- Financial results
22 Jul - Prolife reported FY26 audited results, PAT 425.39 lakh, unmodified opinion, and appointed Paresh V. Soni & Co. as internal auditor. 22 Jul - Prolife reported FY26 audited results, PAT 425.39 lakh, unmodified opinion, and appointed Paresh V. Soni & Co. as internal auditor.
4
Outcome of Board Meeting
20 Jul - Board approved FY26 audited results, unmodified audit opinion, and appointed M/s Paresh V. Soni & Co. internal auditor. 20 Jul - Board approved FY26 audited results, unmodified audit opinion, and appointed M/s Paresh V. Soni & Co. internal auditor.
5
Certificate under SEBI (Depositories and Participants) Regulations, 2018
9 Jul - Submitted Regulation 74(5) certificate for quarter ended 30 June 2026. 9 Jul - Submitted Regulation 74(5) certificate for quarter ended 30 June 2026.
Frequently Asked Questions about Prolife Industries Ltd
What does Prolife Industries Ltd do?
Incorporated in 1994, Prolife Industries Ltd manufactures intermediates for dyes, pigments, pharmaceuticals, agrochemicals, etc.[1]
Where is Prolife Industries Ltd (PROLIFE) listed?
Prolife Industries Ltd is listed on the Indian stock exchanges. It is listed on NSE: PROLIFE. You can view its live share price, financials, and ratios on Tapetide.
Which sector does Prolife Industries Ltd belong to?
Prolife Industries Ltd operates in the Chemicals sector within the Dyes & Pigments industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
What is the market capitalisation of Prolife Industries Ltd?
Prolife Industries Ltd has a market capitalisation of approximately ₹32.34 Cr. Based on this, it is classified as a Small Cap stock.
What is the PE ratio of Prolife Industries Ltd?
The Price-to-Earnings (PE) ratio of Prolife Industries Ltd is 7.60. The PE ratio compares a company's share price to its earnings per share and is commonly used to assess whether a stock is overvalued or undervalued relative to its peers.
What is the 52-week high and low of Prolife Industries Ltd?
Over the past 52 weeks, Prolife Industries Ltd has traded between a low of ₹56.05 and a high of ₹142.45. This range helps investors understand the stock's price volatility and recent trading levels.
Does Prolife Industries Ltd pay dividends?
Yes, Prolife Industries Ltd has a dividend yield of 0.38%. Dividend yield indicates the annual dividend income relative to the share price. A consistent dividend history can signal financial stability.
What is the Return on Equity (ROE) of Prolife Industries Ltd?
Prolife Industries Ltd has a Return on Equity (ROE) of 10.29%. ROE measures how effectively a company uses shareholders' equity to generate profits. A higher ROE generally indicates better capital efficiency.
How can I research Prolife Industries Ltd on Tapetide?
On Tapetide, you can view Prolife Industries Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.
Company Information
Incorporated in 1994, Prolife Industries Ltd manufactures intermediates for dyes, pigments, pharmaceuticals, agrochemicals, etc.[1]